Welcome to LookChem.com Sign In|Join Free

CAS

  • or

141064-23-5

Post Buying Request

141064-23-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridine oxalate

    Cas No: 141064-23-5

  • No Data

  • No Data

  • No Data

  • BOC Sciences
  • Contact Supplier

141064-23-5 Usage

Description

3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridineoxalate is a complex organic compound characterized by its unique molecular structure. It is derived from a combination of a hexyloxy-substituted thiadiazole and a tetrahydro-1-methylpyridineoxalate moiety. 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridineoxalate exhibits a range of properties that make it suitable for various applications across different industries.

Uses

Used in Pharmaceutical Industry:
3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridineoxalate is used as a therapeutic agent for its potential in treating various medical conditions. Its unique molecular structure allows it to interact with specific biological targets, making it a promising candidate for the development of new drugs.
Used in Chemical Research:
In the field of chemical research, 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridineoxalate serves as a valuable compound for studying its chemical properties, reactivity, and potential applications in the synthesis of other complex molecules.
Used in Material Science:
3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridineoxalate can be utilized in the development of novel materials due to its unique structural features. It may contribute to the creation of advanced materials with specific properties, such as improved stability, enhanced reactivity, or tailored interactions with other molecules.
Used in Agrochemical Industry:
3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridineoxalate may also find applications in the agrochemical industry, where it could be used as an active ingredient in the development of new pesticides, herbicides, or other agricultural chemicals. Its specific properties may provide advantages in terms of efficacy, selectivity, or environmental impact.

Check Digit Verification of cas no

The CAS Registry Mumber 141064-23-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,0,6 and 4 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 141064-23:
(8*1)+(7*4)+(6*1)+(5*0)+(4*6)+(3*4)+(2*2)+(1*3)=85
85 % 10 = 5
So 141064-23-5 is a valid CAS Registry Number.

141064-23-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole,oxalic acid

1.2 Other means of identification

Product number -
Other names XANOMELINE OXALATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:141064-23-5 SDS

141064-23-5Downstream Products

141064-23-5Relevant articles and documents

METHOD OF TREATING SCHIZOPHRENIA

-

, (2008/06/13)

The present invention relates to a novel method for treating a mammal suffering from or susceptible to schizophrenia and schizophreniform diseases by administering thiadiazole or oxadiazole compounds.

METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS

-

, (2008/06/13)

The present invention relates to a novel method for treating a mammal suffering from gastrointestinal motility disorders.

Piperidine compounds and their preparation and use

-

, (2008/06/13)

The present invention relates to therapeutically active piperidine compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebra

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 141064-23-5